NASDAQ:EXAS
EXACT Sciences Corporation Stock News
$62.07
+1.53 (+2.53%)
At Close: May 03, 2024
Exact Sciences (EXAS) Q4 Earnings Top Estimates, Margin Falls
05:11pm, Wednesday, 22'nd Feb 2023 Zacks Investment Research
Robust revenues from the Screening and Precision Oncology segments contributed to the Exact Sciences (EXAS) Q4 top line.
Canaccord Genuity Maintains Buy Rating for Exact Sciences: Here's What You Need To Know
05:00pm, Wednesday, 22'nd Feb 2023 Benzinga
Canaccord Genuity has decided to maintain its Buy rating of Exact Sciences (NASDAQ:EXAS) and raise its price target from $70.00 to $75.00.
Shares of Exact Sciences are trading up 2.32% over the last 2
Exact Sciences (EXAS) Q4 Earnings Top Estimates, Margin Falls
01:33pm, Wednesday, 22'nd Feb 2023
Robust revenues from the Screening and Precision Oncology segments contributed to the Exact Sciences (EXAS) Q4 top line.
Exact Sciences (EXAS) Q4 2022 Earnings Call Transcript
03:30am, Wednesday, 22'nd Feb 2023 The Motley Fool
EXAS earnings call for the period ending December 31, 2022.
Exact Sciences (EXAS) Reports Q4 Loss, Tops Revenue Estimates
10:35pm, Tuesday, 21'st Feb 2023 Zacks Investment Research
Exact Sciences (EXAS) delivered earnings and revenue surprises of 20% and 6.49%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
After-Hours Action: What's Going On With Exact Sciences Stock?
10:17pm, Tuesday, 21'st Feb 2023 Benzinga
Exact Sciences Corp (NASDAQ: EXAS) shares are facing selling pressure after the close on Tuesday on the heels of the company's quarterly results.
What Happened: Exact Sciences said fourth-quarter
Exact Sciences Corporation (EXAS) Q4 2022 Earnings Call Transcript
09:07pm, Tuesday, 21'st Feb 2023
Exact Sciences Corporation (NASDAQ:EXAS ) Q4 2022 Earnings Conference Call February 21, 2023 5:00 PM ET Company Participants Megan Jones - Investor Relations Kevin Conroy - Chairman and Chief Executiv
Exact Sciences (EXAS) Reports Q4 Loss, Tops Revenue Estimates
06:49pm, Tuesday, 21'st Feb 2023
Exact Sciences (EXAS) delivered earnings and revenue surprises of 20% and 6.49%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
DaVita (DVA) to Report Q4 Earnings: What's in the Offing?
01:06pm, Monday, 20'th Feb 2023 Zacks Investment Research
High labor costs, along with inflationary pressures, are likely to have weighed on DaVita's (DVA) fourth-quarter top line.
5 Large-Cap Stocks Set to Beat on Q4 Earnings This Week
12:11pm, Monday, 20'th Feb 2023 Zacks Investment Research
The following five large-cap stocks are set to beat Q4 earnings estimates this week. These are: TECK, LECO, NI, EXAS and GFL.
5 Large-Cap Stocks Set to Beat on Q4 Earnings This Week
08:17am, Monday, 20'th Feb 2023
The following five large-cap stocks are set to beat Q4 earnings estimates this week. These are: TECK, LECO, NI, EXAS and GFL.
Cathie Wood Bulks Up On Shopify Amid Stock's 18% Post-Earnings Drop, Sells This Major Holding Up 30% This Week
02:35pm, Saturday, 18'th Feb 2023 Benzinga
Cathie Wood’s Ark Invest reversed its stance on Canadian e-commerce retailer Shopify, Inc. (NYSE: SHOP) and began bulking up on the stock this week.
Shopping For Shopify: Ark Invest, through its f
Why Investors Need to Take Advantage of These 2 Medical Stocks Now
01:50pm, Friday, 17'th Feb 2023 Zacks Investment Research
The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now.
Why Investors Need to Take Advantage of These 2 Medical Stocks Now
10:32am, Friday, 17'th Feb 2023
The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now.
Is Exact Sciences or Editas Medicine the Better Growth Stock to Own in 2023?
04:00pm, Thursday, 16'th Feb 2023 The Motley Fool
Which of these rebounding biotech stocks is the better buy right now?
